JMP Securities Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
State Street Corp's Strategic Reduction in Dynavax Technologies Holdings
H.C. Wainwright Maintains Dynavax Technologies(DVAX.US) With Buy Rating, Maintains Target Price $29
Dynavax Technologies Corp (DVAX) Q2 2024 Earnings Call Highlights: Record HEPLISAV-B Sales and ...
Morgan Stanley's List of Tax Loss Selling Stocks
Express News | Deep Track Biotechnology Master Fund, Ltd. Reports 9.56% Stake in Dynavax Technologies Corp as of Sept 16- SEC Filing